1681 fundamentals
CONSUN PHARMACEUTICAL GRP LIMITED financial statements, including revenue, expenses, and profit
The total revenue of 1681 for the last semiannual is 1.84 B HKD, and it's 34.05% higher compared to the previous semiannual. The net income of H2 24 is 554.01 M HKD.
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: HKD
TTM